Public Health Efforts Can Impact Adoption of Current Susceptibility Breakpoints, but Closer Attention from Regulatory Bodies Is Needed
Author(s) -
James A. McKinnell,
Sandeep Bhaurla,
P. Marquez-Sung,
Alicia Pucci,
Merle Baron,
Talar Kamali,
Juliet Bugante,
Benjamin Schwartz,
Sharon Balter,
Dawn Terashita,
Susan M. ButlerWu,
J. D. Gunzenhauser,
Janet A. Hindler,
Romney M. Humphries
Publication year - 2018
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.01488-18
Subject(s) - breakpoint , public health , biology , intensive care medicine , environmental health , medicine , microbiology and biotechnology , pathology , genetics , chromosomal translocation , gene
Microbiological testing, including interpretation of antimicrobial susceptibility testing results using current breakpoints, is crucial for clinical care and infection control. Continued use of obsoleteEnterobacteriaceae carbapenem breakpoints is common in clinical laboratories.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom